Memory in myasthenia gravis: Neuropsychological tests of central cholinergic function before and after effective immunologic treatment

Neurology

Volumn 46, Issue 4, 1996, Pages 1138-1142

  Glennerster, A ^a   Palace, J ^a   Warburton, D ^b   Oxbury, S ^a   Newsom Davis, J ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR; PLACEBO; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEARNING TEST; MALE; MEMORY; MUSCLE STRENGTH; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TASK PERFORMANCE;

EID: 0029866471     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.4.1138     Document Type: Article

References (22)

1. Drachman DB, Adams RN, Stanley EF, Pestronk A. Mechanisms of acetylcholine receptor loss in myasthenia gravis. J Neurol Neurosurg Psychiatry 1980;43:601-610.
2. Kopelman MD, Corn TH. Cholinergic 'blockade' as a model for cholinergic depletion: a comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 1988;111:1079-1110.
3. Lefvert AK, Pirskanen R. Acetylcholine receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis. Lancet 1977;2:351-352.
4. Keesey JC, Tourtellotte WW, Herrmann C, Andrews JM, Lindstrom J. Acetylcholine-receptor antibody in cerebrospinal fluid. Lancet 1978;1:777.
5. Bergonzi P, Mazza S, Mennuni G, Morante M, Sollazzo D, Scoppetta C. Central nervous system involvement in myasthenia gravis. Ann NY Acad Sci 1981;377:810-811.
6. Papazian O. Rapid eye movement sleep alterations in myasthenia gravis. Neurology 1976;26:311-316.
7. Fulpius BW, Fontana A, Cuénoud S. Central nervous system involvement in experimental autoimmune myasthenia gravis. Lancet 1977;2:350-351.
8. Tucker DM, Roeltgen DP, Wann PD, Wertheimer RI. Memory dysfunction in myasthenia gravis: evidence for central cholinergic effects. Neurology 1988;38:1173-1177.
9. Davidov-Lustig M, Klinghoffer V, Kaplan-Dinur A, Steiner I. Memory abnormalities in myasthenia gravis: possible fatigue of central nervous system cholinergic circuits. Autoimmunity 1992;14:85-86.
10. Lewis SW, Ron MA, Newsom-Davis J. Absence of central function cholinergic deficits in myasthenia gravis. J Neurol Neurosurg Psychiatry 1989;52:258-261.
11. Wesnes K, Warburton DM. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl) 1984;82:147-150.
12. Revell AD. Smoking and performance: a puff-by-puff analysis. Psychopharmacology (Berl) 1988;96:563-565.
13. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl) 1992;108: 485-494.
14. McNicol D. A primer of signal detection theory. London: George Allen and Unwin Ltd, 1972.
15. Peterson LR, Peterson MJ. Short-term retention of individual verbal items. J Exp Psychol 1959;58:193-198.
16. Thorndike EL, Lorge I. The teacher's word book of 30,000 words. New York: Teachers College, Columbia University, 1944.
17. Wechsler DA. Standardised memory scale for clinical use. J Psychol 1945;19:87-95.
18. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1983.
19. Beck AT, Ward CT, Mendelson M, Hock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
20. O Spreen, E Strauss. A compendium of neuropsychological tests: administration, norms and commentary. New York: Oxford University Press, 1991.
21. Miller RG. Simultaneous statistical inference. New York: McGraw Hill, 1966.
22. Sahakian B, Jones G, Levy R, Gray J, Warburton D. The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 1989;154:979-800.